Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120091) titled 'Study on the human efficacy of pyrroloquinoline quinone disodium salt capsules (Vigou Full PQQ)' on March 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Changsha Taihe Hospital
Condition:
Healthy person
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-03-09
Target Sample Size: Test group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=313099
Published by HT Digital Content Services with permission from Health Daily Digest....